Preclinical and post-treatment changes in the HCC-associated serum proteome. - Test2 - elhamkhani - TriplyDB

Preclinical and post-treatment changes in the HCC-associated serum proteome.

Preclinical and post-treatment changes in the HCC-associated serum proteome.

http://www.wikidata.org/entity/Q33261336

about

Biomarker discovery in infectious diseases using SELDI.Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants.The current state of proteomics in GI oncology.Proteomic profiling of urine for the detection of colon cancer.Proteomics and liver fibrosis: identifying markers of fibrogenesis.Biomarker studies on radiotherapy to hepatocellular carcinoma.Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma.A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

P2860

Q33292219-B85545A9-F73D-44C0-B68D-2650CA8393DF Q34028660-FF8262B0-AEA6-4BAB-9F14-91A8002DEE68 Q34608851-3E68F313-8005-4921-8AD6-30655B78670D Q36736959-2778BFEA-A061-46CB-AAC5-54D20DC71F9D Q37579910-99E99728-9B40-4AAE-AE59-759E92F8E49E Q38083433-39565D52-A45C-4E12-8B88-843EBED2C0B6 Q38397273-B5BE67C5-F408-43F7-876C-A13B705EB241 Q39140382-DF1F267F-B057-41DB-9A2B-AEEBC41080ED Q42594913-AD10B05C-3476-4AA0-85AB-702B14229AB7

P2860

Preclinical and post-treatment changes in the HCC-associated serum proteome.

http://www.wikidata.org/entity/Q33261336

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@ast

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@en

type

label

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@ast

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@en

prefLabel

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@ast

Preclinical and post-treatment changes in the HCC-associated serum proteome.

@en

P1433

Q33261336-8C140893-A21A-4FFB-9FFA-BE3049E4F14F

P1476

Q33261336-45CF82E6-BDB3-46C9-B716-2ED868782D3E

P2093

Q33261336-279C2A31-BE13-4076-B113-3EBAA1D9C94E

Q33261336-5218BA53-B53E-4375-81E9-695E0B069DA0

Q33261336-630FA417-2880-4B88-851B-3036F7AFE1D1

Q33261336-63375EE1-E239-4981-8A97-71FD77A5F77C

Q33261336-9D284BD7-2BA7-43AD-9D48-64401B808710

Q33261336-B2D2F607-7BA4-468C-9B8A-F86681F56FE2

Q33261336-CFB5984D-EEF2-4727-AB1C-04496A22BE05

P2860

Q33261336-277E4E20-0414-4826-A195-ADEFA68B864A

Q33261336-2A8BE945-D6FF-42D1-940F-CD971C303A23

Q33261336-3286780C-88A6-4CB6-8174-5AF1F1C3EBA3

Q33261336-3F32B1FC-55A5-49D0-B0EF-F54B70D8B034

Q33261336-40EC5CA0-AB97-42C4-A8AB-3A1585841ECF

Q33261336-43D058A2-0FED-4EF2-A837-14D3B31C4FAB

Q33261336-4B43FBFC-C11C-42E8-95B7-4DC3AB682CF3

Q33261336-59DF406B-A730-4239-9871-7BCE2A2BBC9A

Q33261336-6079F4BE-C156-413D-983D-F31C0AA28C0D

Q33261336-62645C3F-B394-4291-B107-1BD46BD2606A

P2888

Q33261336-96A72DD6-3BF0-4AE5-8AF1-889CE7AE47B7

P304

Q33261336-E20D1C69-2399-4194-B813-34F4C147C183

P31

Q33261336-BD7B8B7B-1A32-42F2-AAB2-07321147AA36

P356

Q33261336-D5703B21-2DE9-4E74-B7A7-F1BC8BEC1E42

P407

Q33261336-8AB05942-3BFD-489C-8900-9938B6C8CB35

P433

Q33261336-3BD645DC-DC4B-4683-8F24-67E47A6E01A5

P478

Q33261336-D04A0AE7-EC14-4CDF-A430-ADEC110D6F94

P50

Q33261336-67869B7D-FD7D-41FE-98BE-257420FB5DF4

Q33261336-840775EB-0EE1-49AD-BE4D-75A784382BBA

P577

Q33261336-7D971136-75E1-4114-ACD4-A5793C7E7DCC

P5875

Q33261336-4F5EC6AE-198F-45A5-94E8-BED3C0BC4362

P6179

Q33261336-15B2A6B3-9D80-4ED5-8EDA-479B645F5CA7

P698

Q33261336-EB79AE8E-140F-4BEF-8E21-F1DF0C6BB66A

P932

Q33261336-4ACC7A24-CEDC-4070-8A9E-277A0CE23F81

P356

P1433

British Journal of Cancer

P1476

Preclinical and post-treatment changes in the HCC-associated serum proteome

@en

P2093

A Martin

http://www.w3.org/2001/XMLSchema#string

G N'Kontchou

http://www.w3.org/2001/XMLSchema#string

M Beaugrand

http://www.w3.org/2001/XMLSchema#string

N Barget

http://www.w3.org/2001/XMLSchema#string

P J Johnson

http://www.w3.org/2001/XMLSchema#string

T T Thar

http://www.w3.org/2001/XMLSchema#string

Y Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Application of serum SELDI proteomic patterns in diagnosis of lung cancer

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population.

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

P2888

P304

1379-1383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603429

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Douglas G. Ward

P577

2006-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6735021

http://www.w3.org/2001/XMLSchema#string

P6179

1035090183

http://www.w3.org/2001/XMLSchema#string

P698

17060939

http://www.w3.org/2001/XMLSchema#string

P932

2360589

http://www.w3.org/2001/XMLSchema#string